Видео ютуба по тегу Immunogenicity R

General principles Clinical interpretation of immunogenicity
General principles Clinical interpretation of immunogenicity
Immunogenicity overview of therapeutic biologics
Immunogenicity overview of therapeutic biologics
Daron Forman: The use of immunogenicity risk assessment tools for lead optimization of biologics
Daron Forman: The use of immunogenicity risk assessment tools for lead optimization of biologics
A View On the Importance of Immunogenicity
A View On the Importance of Immunogenicity
Immunogenicity -Properties determining immunogenicity of a substance (FL-Immuno/21)
Immunogenicity -Properties determining immunogenicity of a substance (FL-Immuno/21)
Robin Thorpe: European Regulatory Guidance for Unwanted Immunogenicity
Robin Thorpe: European Regulatory Guidance for Unwanted Immunogenicity
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Immunogenicity explained in 6 minutes
Immunogenicity explained in 6 minutes
Clinical relevance of immunogenicity to biologics
Clinical relevance of immunogenicity to biologics
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Valerie Quarmby: Assessing immunogenicity risk in biotherapeutic development
Valerie Quarmby: Assessing immunogenicity risk in biotherapeutic development
Bernd Schlereth: Mastering Pharmacokinetics and Immunogenicity of bispecific antibodies
Bernd Schlereth: Mastering Pharmacokinetics and Immunogenicity of bispecific antibodies
Andrea Ferrante: In-silico prediction of immunogenicity: filling the gaps
Andrea Ferrante: In-silico prediction of immunogenicity: filling the gaps
2022 Immunogenicity 101 how and when the immune system reacts to drugs
2022 Immunogenicity 101 how and when the immune system reacts to drugs
Antigenicity and Immunogenicity (FL-Immuno/20)
Antigenicity and Immunogenicity (FL-Immuno/20)
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Towards Understanding HLA-DQ Immunogenicity
Towards Understanding HLA-DQ Immunogenicity
Jeremy Fry: An Integrated Approach to Managing Immunogenicity Risk and Optimum Protein Design
Jeremy Fry: An Integrated Approach to Managing Immunogenicity Risk and Optimum Protein Design
Microbiota-Regulated Immunity | Dan Littman | Immunoschool 2025
Microbiota-Regulated Immunity | Dan Littman | Immunoschool 2025
Bartek Zuber: Immunogenicity assessment for Affibody-Fc fusion therapeutics
Bartek Zuber: Immunogenicity assessment for Affibody-Fc fusion therapeutics